4//SEC Filing
Tregoning Kathleen 4
Accession 0000899243-23-000990
CIK 0001701108other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:16 PM ET
Size
5.9 KB
Accession
0000899243-23-000990
Insider Transaction Report
Form 4
Tregoning Kathleen
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-01-03$1.29/sh+30,943$39,916→ 30,943 totalExercise: $1.74Exp: 2033-01-03→ Common Stock (30,943 underlying)
Footnotes (2)
- [F1]This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.
- [F2]This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $40,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001830764
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:16 PM ET
- Size
- 5.9 KB